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Abstract
Background Type D personality is an emerging risk factor
in coronary artery disease (CAD). Cardiac rehabilitation
(CR) improves outcomes, but little is known about the
effects of CR on Type D patients.
Purpose We examined (1) variability in Type D caseness
following CR, (2) Type D as a determinant of health status,
and (3) the clinical relevance of Type D as a determinant of
health status compared to cardiac history.
Methods CAD patients (n=368) participating in CR com-
pleted the Type D Scale, the Short-Form Health Survey 36
pre- and post-CR, and the Hospital Anxiety and Depression
Scale pre-CR, to assess health status and depressive and
anxious symptomatology, respectively.
Results The prevalence of Type D decreased from 26.6%
to 20.7% (p=0.012) following CR, but Type D caseness
remained stable in 81% of patients. Health status signifi-
cantly improved following CR [F(1,359)=17.48, p<0.001],
adjusting for demographic and clinical factors and anxious
and depressive symptoms. Type D patients reported poorer
health status [F(1,359)=10.40, p=0.001], with the effect of
Type D being stable over time [F(1,359)=0.49, p=0.48].
Patients with a cardiac history benefited less from CR
[F(1,359)=5.76, p=0.02]. The influence of Type D on health
status was larger compared to that for cardiac history, as
indicated by Cohen’s effect size index.
Conclusions Type D patients reported poorer health status
compared to non-Type D patients pre- and post-CR. In the
majority of patients, CR did not change Type D caseness, with
Type D being associated with a stable and clinically relevant
effect on outcome. These high-risk patients should be identified
in clinical practice and may require adjunctive interventions.
Keywords Cardiac rehabilitation . Coronary artery disease .
Health status . Type D personality
Introduction
Cardiac rehabilitation comprises an important adjunctive
treatment option for patients with coronary artery disease
(CAD) once they are medically stable, with benefits
extending from improvements in well-being [1, 2] and
health status [3] to clinical outcome [4], including enhanced
survival [5]. However, subgroups of patients may not
benefit optimally from cardiac rehabilitation, with clinical
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factors, such as comorbid chronic kidney disease [6], type
II diabetes [7], and obesity [8], and psychological factors,
such as depressive mood states [9], having been shown to
moderate the effectiveness of cardiac rehabilitation.
Personality comprises another potentially important
determinant of health outcomes following cardiac rehabil-
itation, which to date has received little attention. Prelim-
inary evidence indicates that hostile patients may
experience more benefits from cardiac rehabilitation in
terms of reductions in anxiety and improvement in quality
of life [10]. Type D personality is an emerging risk factor in
cardiovascular disease that has been shown to predict
adverse health outcomes in CAD [11, 12], peripheral
arterial disease [13], chronic heart failure [14], patients
with life-threatening arrhythmias [15], and patients treated
with revascularization procedures [16]. Type D is defined
by the two normal and stable personality traits Negative
Affectivity [17] and Social Inhibition [18]. Patients with
this personality disposition often feel sad, have a gloomy
view of life, and at the same time do not express these
emotions in social interactions because of fear of disap-
proval or rejection by others [19].
Type D personality has been associated with adverse
prognosis at 5 years follow-up, despite optimal medical
treatment and participation in cardiac rehabilitation [11].
However, the latter study did not include assessments pre-
and post-cardiac rehabilitation. Two recent studies focused
on Type D within the cardiac rehabilitation setting. One
showed that Type D patients benefit from cardiac rehabil-
itation in terms of improved health status and a reduction in
depression and anxiety [20]. However, analyses were
performed in a small sample (n=55) of patients, with the
authors not adhering to the standardized fashion for
determining Type D caseness. The other study showed that
81% of patients remained stable in Type D caseness after
attending cardiac rehabilitation [21].
The objectives of the current prospective study, using a
between-subjects design, were (1) to determine variability
in Type D caseness following cardiac rehabilitation, (2) to
examine whether Type D personality is a determinant of
health status in patients attending cardiac rehabilitation, and
(3) to evaluate the clinical relevance of Type D personality
as a determinant of impaired health status compared to
cardiac history prior to the referral event.
Method
Study Design and Participants
Consecutive patients with established heart disease referred to
the cardiac rehabilitation program at the Rotterdam Organiza-
tion for Cardiac Rehabilitation, The Netherlands, between
March 2004 and October 2005, participating in the identifica-
tion of subgroups of heart patients that may not benefit
optimally from cardiac rehabilitation (HEARTCARE) study,
comprised the sample for the current study. Patients with
chronic heart failure (due to participation in another study
within the institution) and those with insufficient knowledge of
the Dutch language to be able to complete questionnaires were
excluded, leaving 519 patients eligible for participation. Of
these patients, 111 were lost to follow-up, and 29 patients did
not complete baseline assessment. In addition, 11 patients were
excluded from analyses because of too many missing data on
questionnaires. Final analyses were based on 368 patients
(response rate=71.2%). Patients were asked to complete a set
of psychological questionnaires at baseline and at 3-month
follow-up (i.e., prior to and after completion of the rehabili-
tation program). The study was set up as a between-subjects
design, and not as a randomized controlled trial, because it was
not possible to have a waiting list control group in the current
cardiac rehabilitation setting.
The study protocol was approved by the medical ethics
committee of the Erasmus Medical Center, Rotterdam. The
study was conducted according to the Helsinki Declaration,
and every patient provided written informed consent.
Contents of Rehabilitation Program
The program was multi-factorial comprising an introductory
module, physical exercise component, modules on risk
factors, stress management, diet, medication, weight loss,
and smoking cessation, with the possibility of having
individual counseling by a psychiatrist, psychologist, or
social worker if requested by the patient.
Materials
Demographic and Clinical Variables
Demographics included gender, age, educational level, marital
status, and employment status. Clinical variables, obtained
from the patients’ medical records, included initial diagnosis,
cardiac history prior to the referral event (i.e., previous
myocardial infarction, coronary artery bypass graft surgery, or
percutaneous coronary intervention), prescribed medications,
smoking, and risk factors (i.e., hypercholesterolemia, hyper-
tension, diabetes, family history, renal insufficiency, chronic
obstructive pulmonary disease, and liver insufficiency).
Type D Personality
The Type D Scale (DS14) was administered to assess Type
D personality [22]. This 14-item questionnaire comprises
two subscales, Negative Affectivity and Social Inhibition,
each consisting of seven items. Items are answered on a
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five-point Likert scale, ranging from 0 (false) to 4 (true). A
standardized cut-off score ≥10 on both subscales is used to
classify individuals with a Type D personality [22]. A
previous study confirmed that it is the interaction of both
traits, rather than the single traits, that incurs an increased
risk of adverse health outcomes [23]. Recently, the cut-off
score of ≥10 for both subscales has been confirmed as the
most optimal by means of Item Response Theory in
samples from the general population, CAD patients, and
hypertensives [24]. Both of the DS14 subscales of Negative
Affectivity and Social Inhibition have good internal
consistency (Cronbach’s α=0.88/0.86), are stable over a
3-month period (r=0.82/0.72), and are independent of
mood and health status [22]. In the current sample, the 3-
month test–retest reliability for the Negative Affectivity and
the Social Inhibition components were 0.64 and 0.74,
respectively. A recent study in post-myocardial infarction
patients confirmed the stability of Type D personality
during an 18-month period and that Type D is not
confounded by disease severity and mood states [25, 26].
Depressive and Anxious Symptomatology
The Dutch version of the Hospital Anxiety and Depression
Scale (HADS) was used to assess depressive and anxious
symptomatology [27, 28]. Both subscales consist of seven
items that are answered on a four-point Likert Scale, ranging
from 0 to 3. A cut-off score of ≥8 for each subscale
represents probable clinical levels of anxiety and depression
[29]. Test–retest reliability over a 3-week period for the
subscales and the total scale are good (0.86<r<0.91) [28].
The dimensional structure and reliability of the HADS has
shown to be stable across medical settings and age groups [28].
Health Status
The Dutch version of the Short-Form Health Survey (SF-36)
was administered to assess generic health status [30, 31].
Items are answered according to standardized response
choices and contribute to eight subscales: Physical Func-
tioning (ten items), Social Functioning (two items), Role
Limitations due to Physical Functioning (four items), Role
Limitations due to Emotional Functioning (three items),
Mental Health (five items), Vitality (four items), Bodily Pain
(two items), and General Health (five items). Raw scores
were transformed to scale scores according to standard
scoring procedures. Subscale scores range from 0–100, with
higher scores indicating better levels of functioning. For the
Bodily Pain subscale, a higher score denotes the absence of
pain. The validity and reliability of the Dutch SF-36 are good
[31]. The mean alpha coefficient across groups from the
Dutch general population, migraine patients, and cancer
patients and across scales was 0.84 [31].
Statistical Analyses
Discrete variables were compared with the chi-square test and
continuous variables with Student’s t test for independent
samples. Analyses were adjusted for multiple comparisons
by means of a Bonferroni correction (α/number of compar-
isons). The McNemar test was used to examine whether
Type D and non-Type D proportions were equally distrib-
uted pre- and post-cardiac rehabilitation. Secondary analyses
were conducted to determine whether the two subcompo-
nents of Type D personality, Negative Affectivity, and
Social Inhibition, changed following cardiac rehabilitation.
To examine differences in health status between Type D
and non-Type D patients prior to and after cardiac rehabili-
tation, we used multivariate analysis of variance (MANOVA)
with repeated measures in order to adjust for multiple
comparisons, given that the SF-36 comprises eight subscales.
Multivariate analysis of covariance (MANCOVA) with
repeated measures was performed to adjust for the effect of
potential confounders on the relationship between Type D
personality and health status. In MANOVA as well as
MANCOVA, baseline Type D personality classification was
entered as a between-subjects factor and health status as a
within-subjects factor. Age, gender, smoking, cardiac history
prior to the referral event, comorbidity (chronic obstructive
pulmonary disease, diabetes, or renal insufficiency), anxiety,
and depressive symptoms at baseline were selected as
covariates a priori based on the literature. Post-hoc paired-
samples t tests were conducted to determine differences in
domains of health status for Type D and non-Type D
patients separately.
Secondary analyses were conducted on the subsample of
patients for whom information was available on individual
counseling to determine whether these patients differed on
health status prior to and following cardiac rehabilitation
from patients who did not receive individual counseling. To
evaluate the clinical relevance of Type D personality
compared to cardiac history prior to the referral event as a
determinant of impaired health status pre- and post-cardiac
rehabilitation, effect sizes were calculated, using Cohen’s d
[32, 33]. Cohen’s d represents the differences between
means (i.e., Type D vs. non-Type D; cardiac history vs. non
cardiac history prior to the referral event) divided by the
pooled standard deviation. An effect size ranging from 0.00
to 0.20 is negligible to small, 0.20 to 0.50 small to
moderate, 0.50 to 0.80 large, and >0.80 very large [33].
Cardiac history prior to the referral event was chosen as
comparison, since this variable previously has been shown
to moderate the effectiveness of a behavioral intervention in
vitally exhausted patients undergoing a percutaneous
coronary intervention [34]. A post-hoc power analysis
showed that, with an assumed effect size of 0.20, α=0.05,
and a power of 95%, a sample size of 327 patients was
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required to detect statistical differences in SF-36 scores pre-
and post-cardiac rehabilitation (repeated measures design,
within-between interaction). This assumption was met,
since analyses were based on 368 patients. All statistical
tests were two-tailed, and p<0.05 was used to indicate
statistical significance. Statistical analyses were performed
using SPSS 14.0 for Windows (SPSS Inc., Chicago, IL,
USA).
Results
Patient Characteristics
Completers (n=368) and non-completers (n=151) of the
cardiac rehabilitation program did not differ on baseline
demographic and clinical characteristics. There were also
no statistically significant differences in the prevalence of
Type D personality for those non-completers with data on
Type D status (n=111) and completers (n=368; χ2=0.08,
p>0.05).
The prevalence of Type D personality was 26.6%.
Patient baseline characteristics, stratified by Type D, are
presented in Table 1. No differences were found between
Type D and non-Type D patients on baseline demographic
and clinical characteristics and the type of cardiac rehabil-
itation-components attended.
Changes in Type D Caseness and Components Following
Cardiac Rehabilitation
There was a 5.9% reduction in the number of patients with a
Type D personality from 26.6% prior to cardiac rehabilitation
to 20.7% post-cardiac rehabilitation (χ2=6.30, p=0.012). A
change in Type D caseness was found in 19% of patients,
with caseness remaining stable in 81%. Of the 19% crossing
Table 1 Baseline characteristics stratified by Type D personality
Total sample (n=368) Type D (n=98) Non-Type D (n=270) pa
Socio-demographics
Males 290 (78.8) 73 (74.5) 217 (80.4) 0.22
Age, mean (SD) 58.1 (10.2) 57.4 (10.3) 58.3 (10.2) 0.45
Having a partner 330 (89.7) 87 (87.8) 244 (90.4) 0.47
Clinical variables
Cardiac event prior to referral eventb 299 (81.3) 79 (80.6) 220 (81.5) 0.85
Diabetes mellitus 54 (14.7) 16 (16.1) 38 (16.3) 0.59
Dyslipidemia 185 (50.3) 55 (56.1) 130 (48.1) 0.18
Hypertension 122 (33.2) 32 (32.7) 90 (33.3) 0.90
Renal impairment 4 (1.1) 2 (2.0) 2 (0.7) 0.29
Chronic obstructive pulmonary disease 28 (7.6) 7 (7.1) 21 (7.8) 0.84
Currently smoking 32 (8.7) 12 (12.2) 20 (7.4) 0.15
Medication
β-Blockers 286 (77.7) 75 (76.5) 211 (78.1) 0.74
ACE inhibitors 215 (58.4) 56 (57.1) 159 (58.9) 0.77
Calcium antagonists 42 (11.4) 13 (13.3) 29 (10.7) 0.50
Nitrates 118 (32.1) 27 (27.6) 91 (33.7) 0.26
Statins 298 (81.0) 83 (84.7) 215 (79.6) 0.27
Aspirin 277 (75.3) 78 (79.6) 199 (73.7) 0.25
Diuretics 66 (17.9) 17 (17.3) 49 (18.1) 0.86
Cardiac rehabilitation componentsc
Introduction 144 (44.4) 41 (50.0) 103 (42.6) 0.24
Risk factors 251 (77.0) 69 (82.1) 182 (75.2) 0.19
Dietary advice 238 (73.0) 67 (79.8) 171 (70.7) 0.11
Medication 196 (59.0) 54 (64.3) 142 (57.3) 0.26
Physical exercise 327 (98.8) 83 (100) 244 (98.4) 0.24
Stress-management 61 (18.4) 15 (17.9) 46 (18.6) 0.88
Smoking cessation 26 (7.83) 8 (9.5) 18 (7.3) 0.50
Weight loss 53 (16.0) 13 (15.5) 40 (16.1) 0.89
Individual counseling 48 (14.5) 18 (21.4) 30 (12.2) 0.04
Results are presented as n (%) unless otherwise stated.
a p values adjusted for multiple comparisons.
b Coronary artery bypass grafting, myocardial infarction, or percutaneous coronary intervention.
c Due to missing data for 36–44 patients, analyses were conducted on available data.
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over, 6.5% crossed over from non-Type D to Type D,
whereas 12.5% crossed over from Type D to non-Type D.
Of the 81% maintaining their caseness over time, 66.9% and
14.1% were consistently categorized as non-Type D and
Type D, respectively. No statistically significant differences
were found between patients crossing-over and remaining
stable on Type D caseness on the cardiac rehabilitation
components attended (7.25<χ2<0.08, all ps>0.05). Hence,
the cross-over from Type D to non-Type D and vice versa
could not be attributed to differences in participation in the
various cardiac rehabilitation components. Generally, in the
subsample of patients for whom information on individual
counseling was collected (n=331), there was no statistically
significant difference in health status pre- and post-rehabil-
itation between patients receiving and not receiving indi-
vidual counseling [F(1,329)=0.91, p=0.34]. The main
effect for individual counseling and the interaction effect
for time by individual counseling were significant [F(1,329)
=12.76 and F(1,329)=8.60, both ps<0.01]. After control-
ling for possible confounders, the main effect for time did
not remain significant [F(1,323)=1.21, p=0.27]. In addition,
the interaction for time by individual counseling, as well as
the main effect for individual counseling, were no longer
significant [F(1,323)=1.31, p=0.25 and F(1,323)=1.12, p=
0.29, respectively].
To determine whether the Type D subcomponents
changed following cardiac rehabilitation, we conducted a
MANOVA with repeated measures. There was a significant
main effect for time for Social Inhibition and Negative
Affectivity [F(1,367)=6.48, p=0.01 and F(1,367)=35.35,
p<0.001, respectively], indicating that there was a decrease
in scores over time. After controlling for possible con-
founders, using MANCOVA with repeated measures, the
main effect for time lost significance for Negative Affec-
tivity [F(1,360)=0.29, p=0.59]. Covariates did not interact
with time [0.05<F(1,360)<2.30, all ps<0.05]. The main
effect for time for Social Inhibition remained significant
[F(1,360)=6.74, p=0.01] in adjusted analysis. The time by
cardiac history was also significant, indicating that patients
who experienced a cardiac event prior to the index event
[F(1,360)=12.54, p<0.001] reported changes in Social
Inhibition. Post-hoc paired t tests showed that both Social
Inhibition [from 9.44±5.62 to 8.13±6.14; t(367)=2.55,
p=0.01] as well as Negative Affectivity [from 8.90±5.89 to
8.22±6.09; t(367)=5.95, p<0.001] decreased significantly.
However, the clinical relevance of these decreases were
negligible to small for Negative Affectivity (d=0.11) and
small for Social Inhibition (d=0.22), as indicated by
Cohen’s effect size index.
Type D Personality as a Determinant of Health Status
Pre- and Post-Cardiac Rehabilitation (Unadjusted Analysis)
MANOVAwith repeated measures demonstrated a significant
within subjects effect for time [F(1,366)=222.63, p<0.001],
indicating that health status, as assessed by the SF-36,
improved over time. The time by Type D interaction was not
significant, showing that Type D personality exerted a stable
effect on health status over time [F(1,366)=1.43, p=0.23].
However, patients with a Type D personality reported
significantly poorer health status [F(1,366)=80.80,
p<0.001] compared to non-Type D patients. Mean scores
(SD) on health status pre- and post-cardiac rehabilitation
stratified by Type D personality are presented in Table 2.
Type D Personality as a Determinant of Health Status
Pre- and Post-Cardiac Rehabilitation (Adjusted Analysis)
MANCOVAwith repeated measures showed a main effect for
time [F(1,359)=17.48, p<0.001], indicating an overall
improvement in health status over time when correcting for
potential confounders. Furthermore, the interaction effect for
time by cardiac history prior to the referral event was
significant, denoting that patients with a prior cardiac history
reported impaired health status pre- and post-cardiac rehabil-
itation compared to patients without a cardiac history prior to
Table 2 Mean (SD) SF-36 scale scores stratified by Type D personality
Pre-CR Post-CR
Type D Non-Type D Type D Non-Type D
Physical Functioning 61.12 (19.73) 73.12 (18.63) 75.41 (21.03) 84.81 (15.50)
Social Functioning 56.82 (25.50) 71.98 (20.06) 71.94 (22.19) 85.68 (17.37)
Role limitations due to Physical Functioning 11.48 (11.48) 34.72 (38.43) 54.46 (38.18) 71.98 (36.87)
Role limitations due to Emotional Functioning 38.10 (39.11) 64.51 (39.78) 65.14 (40.45) 85.83 (26.72)
Mental Health 56.22 (17.42) 75.21 (16.99) 65.04 (16.28) 81.25 (15.14)
Vitality 47.65 (17.54) 62.10 (19.17) 57.20 (17.63) 69.65 (18.27)
Bodily Pain 56.42 (15.55) 56.49 (17.27) 49.33 (14.96) 50.59 (11.36)
General Health 60.63 (15.18) 66.07 (15.21) 61.63 (20.04) 69.54 (18.67)
A higher score represents better health status, with a higher score on Bodily Pain indicating the absence of pain.
CR Cardiac rehabilitation, SD standard deviation
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the referral event [F(1,359)=5.76, p=0.02]. Comorbidity,
age, gender, smoking, anxiety, and depressive symptoms did
not interact with cardiac rehabilitation [0.001<F(1,359)<2.32,
p>0.05]. The time by Type D was not significant, indicating
that Type D had a stable effect on health status over time [F
(1,359)=0.49, p=0.48]. The between-subjects effect for Type
D personality remained significant, showing that Type Ds
and non-Type Ds differed on self-reported health status [F
(1,359)=10.40, p=0.001] as measured by the SF-36.
Paired samples t tests for Type D patients demonstrated
improvements on six subscales of the SF-36 [−10.96<t(97)<
−5.08, all ps<0.001], except for General Health [t(97)=
−0.548, p=0.59]. In addition, Type Ds reported an increase
in Bodily Pain [t(97)=3.24, p=0.002] over time. Non-Type
D patients reported improvements on seven out of eight
subscales [−10.68< t(269)<−3.31, p≤0.001], but they
also reported an increase in Bodily Pain [t(269)=4.82,
p<0.001].
Clinical Relevance of Type D Personality Versus Cardiac
History Prior to the Referral Event
The effect sizes for Type D personality and cardiac history
prior to the referral event, as denoted by Cohen’s effect size
index (d), for all eight SF-36 scale scores pre- and post-
cardiac rehabilitation are presented in Fig. 1. At baseline,
the effect sizes for Type D personality were moderate to
large for five of the eight subscales of the SF-36. The effect
size was very large for Mental Health but small to moderate
for General Health and negligible to small for Bodily Pain
(Fig. 1a). The results remained identical at follow-up,
except for Role Problems due to Physical limitations, where
the effect size decreased to small to moderate. The effect
sizes for cardiac history prior to the referral event at
baseline were small to moderate, except for Mental Health
and Bodily Pain. For these two subscales, the effect sizes
were negligible to small. At follow-up, all effect sizes for
cardiac history prior to the referral event were negligible to
small (Fig. 1b).
Discussion
This study showed that there was a 5.9% reduction in the
number of patients with a Type D personality following
cardiac rehabilitation, although the majority of patients (i.e.,
81%) remained stable within their Type D caseness. The
Type D subcomponent Social Inhibition changed over time,
whereas Negative Affectivity remained stable, but the
clinical relevance of the change in Social Inhibition was
negligible to small, as indicated by Cohen’s effect size
index. Generally, Type D patients reported poorer health
status prior to and after attending a multifactorial cardiac
rehabilitation program compared to non-Type D patients.
Both Type D and non-Type D cardiac patients attending
cardiac rehabilitation reported benefits in terms of health
status, as assessed by the SF-36. Personality did not
moderate the effects of rehabilitation, as indicated by the
non-significant interaction effect for Type D by time,
showing that Type D exerted a stable effect on health
status over time. Cardiac history prior to the referral event
was shown to moderate the effects of cardiac rehabilitation,
with patients with a previous history reporting impaired
health status, as assessed by the SF-36, compared to
patients without a cardiac history prior to the referral event.
The impact of Type D on health status was clinically
relevant compared to cardiac history prior to the referral
event, as indicated by Cohen’s effect size index.
The findings of the current study are in line with previous
studies in patients with peripheral arterial disease [13], treated
with revascularization procedures [16, 35], and patients with
chronic heart failure [14], showing that Type D patients
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Fig. 1 Clinical relevance of Type D personality and cardiac history
prior to the referral event as determinants of health status pre- and
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report poorer health status compared to non-Type D patients
despite both personality taxonomies benefiting from medical
treatment. In the present study, we found a non-significant
interaction effect for Type D personality by time, indicating
that personality did not moderate the effects of cardiac
rehabilitation on health status but exerted a stable effect on
health status over time. In a mixed group of cardiac patients
attending cardiac rehabilitation, patients with a Type D
personality were also shown to report poorer health status,
but this study only evaluated health status at one time point
[19].
In the current study, patients with a cardiac history prior
to the referral event reported impaired health status
compared to patients without a cardiac history. These
findings are in line with the Exhaustion Intervention Trial
(EXIT), which showed that percutaneous coronary inter-
vention patients with a cardiac history prior to the referral
event were less likely to benefit from a behavioral
intervention program designed to improve symptoms of
vital exhaustion [34]. Secondary analyses indicated that, in
particular, patients with two or more previous cardiac
events prior to the index percutaneous coronary interven-
tion benefited less from the intervention. Taken together,
these findings point to the need for individually tailored
interventions for those patients in whom risk factors tend to
cluster together [36]. In addition, they underline that cardiac
rehabilitation should be offered to patients at the time of
their first cardiac event, as they may be more likely to
benefit and adopt life style changes at this time than when
the disease has become chronic [37].
We also found a reduction in the number of patients with
a Type D personality, although the decrease comprised
5.9%. In addition, once categorized as Type D or non-Type
D, the majority of patients (i.e., 81%) maintained their
caseness despite receiving cardiac rehabilitation. These
findings are in line with those of Binder and colleagues
[21] and Karlsson and colleagues [20], although the latter
study deviated from the standard criteria for determining
Type D personality, as originally proposed by Denollet
[22]. Taken together, some patients may cross over from
Type D to non-Type D status, but unfortunately, this only
occurs in a minority of patients, with some patients also
crossing over from non-Type D to Type D status. The
cross-over from Type D to non-Type D status might also be
attributed to measurement error in the instrument. However,
it is important to bear in mind that the present cardiac
rehabilitation program was not specifically designed to
target Type D personality. Future studies are warranted to
determine whether interventions targeting Type D are
effective in improving patient-centered as well as clinical
outcomes in patients with this personality profile.
Limitations of the current study comprise the use of a
generic rather than a disease-specific instrument for the
assessment of health status, as disease-specific instruments
are likely to be more sensitive to tap changes following cardiac
rehabilitation [38]. Incorporation of such instruments might
provide better insight into the facets that may not change
following cardiac rehabilitation. Nevertheless, we were able
to demonstrate changes in a generic measure of health status.
Third, we were not able to control for markers of disease
severity (e.g., left ventricular ejection fraction), as this
information was not standardly noted in the cardiac rehabil-
itation records. Although the relationship between Type D
and health status might be confounded by disease severity,
this seems unlikely given that Type D personality has been
shown not to be confounded by disease severity in post
infarction patients [25, 26]. Fourth, we did not have data on
Type D status for all patients dropping out of the program, with
the possibility that patients dropping out may be more likely to
have a Type D personality. However, we found no differences
in the subsample where this information was available. In
addition, information on the reason for referral to rehabilitation
was not consistently available. Furthermore, the current study
lacked a control group, which hampers interpretation of the
findings. Although it would have been possible to introduce
a waiting group, this was not possible in the current cardiac
rehabilitation setting. Finally, patients diagnosed with chronic
heart failure were excluded from the study. Therefore, results
cannot be generalized to this patient group.
Strengths of the study include the large sample size, with a
post hoc power analysis confirming that the study was
sufficiently powered to test the objectives. Further, we used
a prospective design with repeated measures of health status
and standardized, validated, and psychometrically sound
instruments. Finally, we adjusted statistically for demographic
and clinical factors known to influence health status in CAD.
From a clinical point of view, this study provides further
evidence for the adverse impact on health outcomes and
stability of Type D personality. In addition, the findings
show that the effect of Type D personality on health status
was not only statistically significant but also clinically
relevant. As indicated by Cohen’s effect size index, the
effect sizes for Type D personality ranged from small to
very large both pre- and post-cardiac rehabilitation, with
most effect sizes falling within the range of moderate to
large. In contrast, the effect sizes for cardiac history prior to
the referral event ranged from negligible to moderate at
baseline, whereas at follow-up, all decreased to negligible
to small. These findings are consistent with a previous
study showing that Type D personality was clinically
relevant compared to gender and age as determinants of
vital exhaustion [39]. Despite the majority of patients
remaining Type D or non-Type D post-rehabilitation if
typified as such prior to rehabilitation and Type D exerting
a stable effect on health status over time, Type D patients
experienced improvements in health status, as assessed by
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the SF-36, although their reported health status remained
below par compared to that of non-Type D patients. Taken
together, this suggests that Type D patients benefit from
rehabilitation in terms of improved health status but that
this subgroup of patients need adjunctive interventions to
standard rehabilitation, as they still experience poorer
health status than non-Type D patients. The target of such
intervention should not be to alter personality but to
enhance the coping mechanisms of Type D patients.
These high-risk patients could be identified when
referred for cardiac rehabilitation with the use of the
DS14, as advocated previously [40]. Given that poor health
status is associated with adverse prognosis [41], behavioral
interventions in addition to cardiac rehabilitation may be
warranted for Type D patients. Supplementary interventions
could focus on the pathways that link of Type D personality
to adverse health outcomes. On the behavioral level, self-
management appears to be of importance in this particular
group, with a recent study showing that Type D patients
diagnosed with chronic heart failure are less likely to
consult their cardiologist or heart failure nurse despite
reporting more symptoms and experiencing these as
worrisome [42]. Relaxation therapy, social skills training,
cognitive behavioral therapy, and learning how to deal with
negative emotions could comprise likely adjunctive inter-
ventions to reduce the cardio-toxicity of Type D personal-
ity. Furthermore, therapists involved in intervention trials
targeting Type D should be experienced and sensitive to
establishing and maintaining a safe environment for these
patients, as they are not likely to express and share their
emotions without these premises.
In conclusion, the present study demonstrated that
cardiac patients with a Type D personality report impaired
health status prior to and following cardiac rehabilitation, in
comparison with non-Type D patients. Changes were seen
in Type D caseness following cardiac rehabilitation, but for
the majority of patients once categorized as Type D or non-
Type D, they maintained their caseness despite receiving
cardiac rehabilitation. Type D personality was also shown
to have a stable effect on health status over time. The
impact of Type D personality on health status was not only
statistically significant but also clinically relevant. Taken
together, these findings show that additional intervention is
warranted in this high-risk subgroup. Incorporation of
psychological factors in general and personality factors in
particular in research and clinical practice might enhance
secondary prevention in patients with established CAD.
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